Shenzhen New Industries Biomedical Engineering (300832.SZ) products have obtained IVDR CE certification.
New Industry (300832.SZ) announced recently that the company's human immunodeficiency virus antigen and antibody detection reagents...
Shenzhen New Industries Biomedical Engineering (300832.SZ) announced that their human immunodeficiency virus antigen and antibody test kit (chemiluminescent immunoassay) has obtained the IVDRCE highest risk level Class D certification issued by the EU notified body - TV Sd Deutschland Group.
The new EU regulation on in vitro diagnostic medical devices (IVDR, EU2017/746) replaces the original EU directive on in vitro diagnostic medical devices (IVDD, 98/79/EC) for the management of in vitro diagnostic medical devices in the EU market. As of now, the company has obtained IVDR CE certification for a total of 169 chemiluminescent reagents and 58 biochemical reagents. According to the provisions of the EU regulation on in vitro diagnostic medical devices, the products that have obtained IVDR CE certification this time already have the necessary conditions to enter the EU market, and will further enhance the comprehensive competitiveness of the company's products, which will have a positive impact on the company's future operations.
Related Articles

Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.

Yiwu Huading Nylon (601113.SH) shareholders in Yiwu Economic Development Zone plan to transfer up to 6% of their shares through public solicitation.
Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.

Yiwu Huading Nylon (601113.SH) shareholders in Yiwu Economic Development Zone plan to transfer up to 6% of their shares through public solicitation.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


